"Polypharmacy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. (From Segen, Dictionary of Modern Medicine, 1992)
Descriptor ID |
D019338
|
MeSH Number(s) |
E02.319.698
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Polypharmacy".
Below are MeSH descriptors whose meaning is more specific than "Polypharmacy".
This graph shows the total number of publications written about "Polypharmacy" by people in this website by year, and whether "Polypharmacy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2015 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2017 | 16 | 20 | 36 |
2018 | 24 | 13 | 37 |
2019 | 9 | 14 | 23 |
2020 | 1 | 6 | 7 |
2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Polypharmacy" by people in Profiles.
-
Prevalence and Factors Associated With Polypharmacy Use Among Adult Patients in Saudi Arabia. J Patient Saf. 2021 12 01; 17(8):e1119-e1124.
-
Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic. Qual Life Res. 2022 Jan; 31(1):193-204.
-
Drug-drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain. Sci Rep. 2021 06 14; 11(1):12414.
-
Polypharmacy among COVID-19 patients: A systematic review. J Am Pharm Assoc (2003). 2021 Sep-Oct; 61(5):e14-e25.
-
COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy. J Gerontol A Biol Sci Med Sci. 2021 05 22; 76(6):1068-1073.
-
Trends and concerns of potentially inappropriate medication use in patients with cardiovascular diseases. Expert Opin Drug Saf. 2021 Oct; 20(10):1191-1206.
-
COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies. Biomed Pharmacother. 2021 Aug; 140:111685.
-
Medication adherence in Elderly during COVID-19 pandemic: what role can the emergency department play? Pan Afr Med J. 2021; 38:220.
-
Observations of Polypharmacy and Interactions on Varying COVID-19 Medication Regimens in Nursing Home Residents. J Am Med Dir Assoc. 2021 Mar; 22(3):B22-B23.
-
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study. BMC Med. 2021 02 22; 19(1):51.